| 1IA8 | A: | THE 1.7 A CRYSTAL STRUCTURE OF HUMAN CELL CYCLE CHECKPOINT KINASE CHK1 |
| 1NVQ | A: | THE COMPLEX STRUCTURE OF CHECKPOINT KINASE CHK1/UCN-01 |
| 1NVR | A: | THE COMPLEX STRUCTURE OF CHECKPOINT KINASE CHK1/STAUROSPORINE |
| 1NVS | A: | THE COMPLEX STRUCTURE OF CHECKPOINT KINASE CHK1/SB218078 |
| 1ZLT | A: | CRYSTAL STRUCTURE OF CHK1 COMPLEXED WITH A HYMENALDISINE ANALOG |
| 1ZYS | A: | CO-CRYSTAL STRUCTURE OF CHECKPOINT KINASE CHK1 WITH A PYRROLO-PYRIDINE INHIBITOR |
| 2AYP | A: | CRYSTAL STRUCTURE OF CHK1 WITH AN INDOL INHIBITOR |
| 2GHG | A:2-270 | H-CHK1 COMPLEXED WITH A431994 |
| 2HOG | A: | CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 20 |
| 2QHM | A: | CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 2A |
| 2QHN | A: | CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 1A |
| 2R0U | A: | CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 54 |
| 2X8E | A: | DISCOVERY OF A NOVEL CLASS OF TRIAZOLONES AS CHECKPOINT KINASE INHIBITORS - HIT TO LEAD EXPLORATION |
| 2YDJ | A:; B: | DISCOVERY OF CHECKPOINT KINASE INHIBITOR AZD7762 BY STRUCTURE BASED DESIGN AND OPTIMIZATION OF THIOPHENE CARBOXAMIDE UREAS |
| 2YWP | A: | CRYSTAL STRUCTURE OF CHK1 WITH A UREA INHIBITOR |
| 3F9N | A: | CRYSTAL STRUCTURE OF CHK1 KINASE IN COMPLEX WITH INHIBITOR 38 |
| 3JVR | A: | CHARACTERIZATION OF THE CHK1 ALLOSTERIC INHIBITOR BINDING SITE |
| 3JVS | A: | CHARACTERIZATION OF THE CHK1 ALLOSTERIC INHIBITOR BINDING SITE |
| 3OT3 | A: | X-RAY CRYSTAL STRUCTURE OF COMPOUND 22K BOUND TO HUMAN CHK1 KINASE DOMAIN |
| 3OT8 | A: | X-RAY CRYSTAL STRUCTURE OF COMPOUND 17R BOUND TO HUMAN CHK1 KINASE DOMAIN |
| 3PA3 | A: | X-RAY CRYSTAL STRUCTURE OF COMPOUND 70 BOUND TO HUMAN CHK1 KINASE DOMAIN |
| 3PA4 | A: | X-RAY CRYSTAL STRUCTURE OF COMPOUND 2A BOUND TO HUMAN CHK1 KINASE DOMAIN |
| 3PA5 | A: | X-RAY CRYSTAL STRUCTURE OF COMPOUND 1 BOUND TO HUMAN CHK1 KINASE DOMAIN |
| 3TKH | A: | CRYSTAL STRUCTURE OF CHK1 IN COMPLEX WITH INHIBITOR S01 |
| 3TKI | A: | CRYSTAL STRUCTURE OF CHK1 IN COMPLEX WITH INHIBITOR S25 |
| 3U9N | A: | X-RAY CRYSTAL STRUCTURE OF COMPOUND 1 BOUND TO HUMAN CHK1 KINASE DOMAIN |
| 4FSM | A: | CRYSTAL STRUCTURE OF THE CHK1 |
| 4FSN | A: | CRYSTAL STRUCTURE OF THE CHK1 |
| 4FSQ | A: | CRYSTAL STRUCTURE OF THE CHK1 |
| 4FSR | A: | CRYSTAL STRUCTURE OF THE CHK1 |
| 4FST | A: | CRYSTAL STRUCTURE OF THE CHK1 |
| 4FSU | A: | CRYSTAL STRUCTURE OF THE CHK1 |
| 4FSW | A: | CRYSTAL STRUCTURE OF THE CHK1 |
| 4FSY | A: | CRYSTAL STRUCTURE OF THE CHK1 |
| 4FSZ | A: | CRYSTAL STRUCTURE OF THE CHK1 |
| 4FT0 | A: | CRYSTAL STRUCTURE OF THE CHK1 |
| 4FT3 | A: | CRYSTAL STRUCTURE OF THE CHK1 |
| 4FT5 | A: | CRYSTAL STRUCTURE OF THE CHK1 |
| 4FT7 | A: | CRYSTAL STRUCTURE OF THE CHK1 |
| 4FT9 | A: | CRYSTAL STRUCTURE OF THE CHK1 |
| 4FTA | A: | CRYSTAL STRUCTURE OF THE CHK1 |
| 4FTC | A: | CRYSTAL STRUCTURE OF THE CHK1 |
| 4FTI | A: | CRYSTAL STRUCTURE OF THE CHK1 |
| 4FTJ | A: | CRYSTAL STRUCTURE OF THE CHK1 |
| 4FTK | A: | CRYSTAL STRUCTURE OF THE CHK1 |
| 4FTL | A: | CRYSTAL STRUCTURE OF THE CHK1 |
| 4FTM | A: | CRYSTAL STRUCTURE OF THE CHK1 |
| 4FTN | A: | CRYSTAL STRUCTURE OF THE CHK1 |
| 4FTO | A: | CRYSTAL STRUCTURE OF THE CHK1 |
| 4FTQ | A: | CRYSTAL STRUCTURE OF THE CHK1 |
| 4FTR | A: | CRYSTAL STRUCTURE OF THE CHK1 |
| 4FTT | A: | CRYSTAL STRUCTURE OF THE CHK1 |
| 4FTU | A: | CRYSTAL STRUCTURE OF THE CHK1 |
| 4GH2 | A: | CRYSTAL STRUCTURE OF THE CHK1 |
| 4HYH | A: | X-RAY CRYSTAL STRUCTURE OF COMPOUND 39 BOUND TO HUMAN CHK1 KINASE DOMAIN |
| 4HYI | A: | X-RAY CRYSTAL STRUCTURE OF COMPOUND 40 BOUND TO HUMAN CHK1 KINASE DOMAIN |
| 4JIK | A: | X-RAY CRYSTAL STRUCTURE OF COMPOUND 22A (R)-2-(4-CHLOROPHENYL)-8-(PIPERIDIN-3-YLAMINO)IMIDAZO[1,2-C]PYRIMIDINE-5-CARBOXAMIDE BOUND TO HUMAN CHK1 KINASE DOMAIN |
)
)